Pinnacle Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Pinnacle Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1K	Buy	+17	New	+$1.14K	﹤0.01%	461

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pinnacle Wealth Advisors's GILD Position: Q2 2021 in Review

Pinnacle Wealth Advisors opened a new position in Gilead Sciences (GILD) in Q2 2021: 17 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #461 among its holdings.

1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

Pinnacle Wealth Advisors held 17 shares of Gilead Sciences worth $1K as of Q2 2021.
Gilead Sciences was a new Pinnacle Wealth Advisors position in Q2 2021.
Gilead Sciences made up ﹤0.01% of Pinnacle Wealth Advisors's portfolio in Q2 2021, its #461 holding.
1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Pinnacle Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.